Cargando…
Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck.
Autores principales: | Gore, M. E., Riches, P., MacLennan, K., O'Brien, M., Moore, J., Dadian, G., Lorentzos, A., Garth, R., Moskovic, E., Archer, D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977791/ https://www.ncbi.nlm.nih.gov/pubmed/1503916 |
Ejemplares similares
-
Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2.
por: Gooding, R., et al.
Publicado: (1995) -
Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma.
por: Johnston, S. R., et al.
Publicado: (1998) -
A randomised dose escalation study of subcutaneous interleukin 2 with and without levamisole in patients with metastatic renal cell carcinoma or malignant melanoma.
por: Ahmed, F. Y., et al.
Publicado: (1996) -
In Our Own Words: The Complex Sensory Experiences of Autistic Adults
por: MacLennan, K., et al.
Publicado: (2021) -
The role of genetic factors in predisposition to squamous cell cancer of the head and neck
por: Jefferies, S, et al.
Publicado: (1999)